Affiliation:
1. Department of Chemistry and Biochemistry, University of Namibia, Namibia
2. Department of Fisheries and Aquatic Sciences, University of Namibia, Namibia
3. School of Pharmacy, University of Namibia, Namibia
Abstract
Plocamium species collected from the Namibian coast display morphological features similar to those of both P. rigidum and P. suhrii which makes identification of these species a difficult task. It has been reported that the major secondary metabolites found in various Plocamium species are unique to each species [1]. In this study GC-MS combined with a retention index (RI) prediction strategy was used for the rapid identification of halogenated monoterpenes characteristic of a particular Namibian Plocamium species. The RIs of the metabolites were matched with the predicted RIs of halogenated monoterpenes for which similar MS data have been reported for the same species of Plocamium. Based on the identification of the major secondary metabolite, 1 E,3 R,4 S,5 E,7 Z-1-bromo-3,4,8- trichloro-7-(dichloromethyl)-3-methylocta-1,5,7-triene [2], it was proposed that these Namibian samples are closely related to that of P. suhrii. From this, it was determined that the proposed P. suhrii specimens collected in Namibia contain four additional metabolites (with molecular formulae C10H16Br2Cl2, C10H11BrCl4, C10H9BrCl6 and an unknown compound) previously not reported in P. suhrii species. In addition, a compound previously identified in South African P. suhrii was not present in the Namibian Plocamium specimens.
Subject
Complementary and alternative medicine,Plant Science,Drug Discovery,Pharmacology,General Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献